NotíciasWhy Novartis Just Surged 6%, Eyeing A Breakout
Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment succeeded in a pair of midstage studies. The post Why Novartis Just Surged 6%, Eyeing A Breakout appeared first on Investor's Business Daily .
Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment succeeded in a pair of midstage studies. The post Why Novartis Just Surged 6%, Eyeing A Breakout appeared first on Investor's Business Daily .
